IMA vs KEYS · rev $9.2M vs P/E 57, rev $4.98B
ImageneBio, Inc. (IMA) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
IMA currently screens at market cap $64.7M. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the IMA and KEYS stock pages for the full models.
Not investment advice.